Panadeine Extra

Quick links to important sections

Panadeine Extra

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Panadeine Extra

Property Description
Active ingredients Acetaminophen and Codeine
Form Tablet or Capsule-shaped tablet
Pharmacological class Combination Opioid Analgesic
Common use Enhanced pain relief and fever reduction
Origin Synthetic/Derived

What Type of Medicine is Panadeine Extra?

Panadeine Extra is a pharmaceutical product formally classified as a fixed-dose combination analgesic, designed for oral consumption, typically supplied as a tablet or capsule-shaped tablet. This medicine belongs to the Combination Opioid Analgesic pharmacological class, a category of pain relievers which combines opioid and non-opioid active ingredients. This indicates the drug is designed for pain that may not respond sufficiently to standard, over-the-counter medication. The product's identity is structurally defined by this dual composition, which is designed to achieve heightened relief by targeting pain through two distinct, complementary mechanisms within a single medicinal entity.

The structural identity confirms its role as a compound preparation, distinguishing it from simple, single-agent formulations. It functions as a systemic medicine, absorbed and distributed throughout the body, intended for patient populations requiring stronger relief than standard pain medications can offer.

Composition: The Dual-Action Active Ingredients

The formulation is centered on the synergistic actions of its two active ingredients: Acetaminophen (Paracetamol) and Codeine, usually in the form of Codeine phosphate. Acetaminophen, a synthetic compound, serves as the non-opioid analgesic and antipyretic component. Codeine is the derived natural opioid component, which acts as a prodrug, converting to its active metabolite, Morphine, to exert its central effects.

This dual composition is responsible for the product's amplified effect, a strategy for managing pain. Combining Acetaminophen with a centrally acting analgesic like Codeine is an established method for addressing moderate-to-severe pain. This shows the combination provides greater efficacy than the individual components.

General Purpose of the Combination

The general therapeutic purpose of this preparation is to provide comprehensive relief for strong pain and moderate pain, along with reducing fever, particularly when single-ingredient pain relievers are deemed insufficient. A typical application involves providing enhanced, short-term relief in situations such as post-operative dental procedures or acute musculoskeletal discomfort. The combined mechanism ensures that both peripheral pain signals and the brain's central perception of pain are addressed simultaneously.

Regulatory References

  1. NIH/StatPearls

What side effects are possible with Panadeine Extra?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety statements for the Acetaminophen/Codeine combination, based strictly on government regulatory documents.

Adverse Reaction Scope

Classification Common System-Organ Effects Serious Adverse Reactions (Label-Documented)
Common Drowsiness, dizziness, sedation, nausea, vomiting, and constipation. These are centrally mediated or gastrointestinal effects. Life-Threatening Respiratory Depression (fatal risk is greatest at treatment initiation or dose increase).
Rare/Not Known Allergic reactions (e.g., skin rash), pruritus, drug dependency (associated with prolonged use), acute pancreatitis. Hepatotoxicity (risk of acute liver failure, associated with the Acetaminophen component).

Population-Specific Safety Constraints

Official labels impose strict restrictions for certain groups where the risks are heightened:

  • Children: The product is contraindicated in children younger than 12 years of age, and in adolescents (under 18) following surgery for tonsil or adenoid removal.
  • Ultra-Rapid Metabolizers: It is contraindicated in individuals known to be ultra-rapid metabolizers of Codeine (CYP2D6 phenotype) due to increased toxicity risk.
  • Breastfeeding Women: Contraindicated as Codeine and its active metabolite, Morphine, can pass into breast milk and pose a risk to the infant.
  • Duration: The risk of Addiction, Abuse, and Dependence is officially noted as a consequence of prolonged use.

Regulatory Safety Summary: The safety profile is structured to clearly define frequently observed, typically non-serious effects from rare but severe events. This requires explicit restrictions for high-risk populations and warnings about the potential for opioid dependence and severe liver damage.

Overdose and Emergency Response

Overdose Manifestations and Clinical Outcomes

Overdose involving this combination product presents two distinct, officially documented toxicological risks: acute hepatotoxicity from the Acetaminophen component and central nervous system (CNS) depression from the Codeine component.

The Acetaminophen component may initially cause non-specific symptoms such as nausea, vomiting, pallor, and abdominal pain. The critical documented outcome is the serious, delayed risk of hepatic necrosis, which can lead to acute liver failure and death. This risk of severe liver damage is officially noted to be increased in patients with pre-existing hepatic impairment or those who chronically consume excessive alcohol.

The Codeine component is associated with clinical manifestations such as extreme somnolence progressing to stupor or coma, circulatory collapse, and life-threatening respiratory depression. Miosis (pinpoint pupils) is a documented sign of toxicity. Special regulatory consideration is noted for children under 12 years due to the unpredictable metabolism of Codeine.

Required Emergency Actions

Government regulatory bodies uniformly mandate that individuals seek immediate medical attention or contact emergency services for any suspected overdose. This action is required even if initial symptoms appear mild or if consciousness is not lost, due to the critical, delayed risk of irreversible liver damage. Officially described management involves monitoring, supportive treatment, and the use of the specific antidotes: N-acetylcysteine for Acetaminophen toxicity and Naloxone for opioid effects.

Therapeutic Uses of Panadeine Extra

What Panadeine Extra Treats: Main Uses and Benefits

Panadeine Extra is generally used to provide effective symptomatic support when the level of discomfort is not adequately managed by single-ingredient pain relievers. It is primarily applied for short-term, acute assistance in managing moderate or strong symptoms.

This medicine is considered relevant for easing symptoms related to physical discomfort and systemic imbalance associated with acute episodes. It is commonly used for headache (including migraine and tension types), toothache, muscle pain, period pain (dysmenorrhoea), and to manage both pain and fever during illnesses like cold or flu.

Quick Fact: Relief for Pronounced Discomfort

The combination is generally applied in scenarios where additional management of discomfort is required, such as following dental procedures or during phases where pain is temporarily disruptive. This dual action supports the patient during difficult episodes by helping to manage symptoms that interfere with daily comfort. The combination can offer supportive relief when acute, heightened symptoms interfere with routine activities, assisting with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

The eligibility for using this medicine is strictly defined by regulatory authorities due to the presence of both acetaminophen and the opioid, codeine. Official guidance establishes clear rules for non-eligibility and conditional use.

Contraindicated Populations Absolute Prohibition
Pediatric Patients Children younger than 12 years of age for all uses.
Post-Surgery Patients under 18 years following tonsillectomy and/or adenoidectomy for obstructive sleep apnoea.
Maternal Status Women who are breastfeeding (Absolute contraindication).
Metabolism Patients known to be CYP2D6 ultra-rapid metabolizers of codeine.

Eligibility is generally reserved for Adults and specific Adolescents (12 years and over) who do not have the conditions listed above. However, conditional use is required for several groups, including the elderly and patients with severe hepatic (liver) or renal (kidney) insufficiency, or a history of drug dependence. Use during pregnancy is advised to be avoided unless specifically directed by a physician.

What should I know about interactions with other medicines?

Panadeine Extra, a combination of paracetamol (acetaminophen) and codeine, can interact with various other medicines and substances. It is essential to inform your doctor or pharmacist about all prescription and non-prescription medicines, herbal remedies, and supplements you are taking.

️ Increased Risk of Sedation and Respiratory Depression

Concomitant use with other medications that slow down the central nervous system (CNS depressants) can lead to profound sedation, difficulty breathing (respiratory depression), coma, and death. This serious interaction is due to the additive effects of the codeine component. Alcohol should be avoided entirely for the same reason.

Type of Interacting Medicine Example Categories
CNS Depressants Benzodiazepines, Sleeping tablets, Tranquilizers, Antipsychotics, Some Antihistamines, Other Opioid pain relievers, Gabapentinoids (e.g., gabapentin and pregabalin)

Other Significant Interactions

  • Other Paracetamol or Codeine Products: Taking Panadeine Extra with any other medicine containing paracetamol or codeine can significantly increase the risk of paracetamol overdose (potentially causing severe liver damage) or excessive codeine-related side effects.
  • Anticoagulants (Blood Thinners): Medicines such as warfarin may have their effects altered when taken with paracetamol, necessitating close monitoring of blood clotting time.
  • Medicines for Nausea/Vomiting: Drugs like metoclopramide and domperidone may increase the absorption of paracetamol, while cholestyramine (for high cholesterol/diarrhea) may decrease it.
  • MAO Inhibitors: Medicines for depression, such as Monoamine Oxidase Inhibitors (MAOIs), should not be taken within 14 days of using codeine, as this can lead to severe adverse reactions.

Mechanism of Action

Panadeine Extra exerts its action through two distinct yet complementary pharmacodynamic pathways that influence specific signaling patterns within the central nervous system (CNS).


Opioidergic Receptor Engagement

This domain covers the action of codeine, a pro-drug that undergoes metabolic conversion to morphine in the liver. Morphine, the active metabolite, binds as an agonist to mu-opioid receptors (MOR) within the CNS. This receptor-mediated signaling initiates sequences that modify early molecular steps, specifically by inhibiting the release of nociceptive neurotransmitters and causing neuronal hyperpolarization. This cascade results in reduced neuronal excitability and altered propagation of afferent signals in the CNS.


Central Modulation of Signaling Pathways

This domain focuses on the action of paracetamol (acetaminophen). It engages mechanisms that modulate key pathways by centrally inhibiting prostaglandin synthesis, potentially via interaction with a variant of the cyclooxygenase enzyme (COX), and by its metabolism to AM404, a compound that activates TRPV1 receptors and acts on the endocannabinoid system. This activity modifies early molecular steps leading to reduced central mediator availability.

Dosage and Administration Information

The administration of the Paracetamol (Acetaminophen) and Codeine combination, often marketed as Panadeine Extra, follows established protocols to ensure appropriate use.

Official Dosing and Administration

Administration Component Instruction
Route Oral administration only, using the tablet or caplet formulation.
Adult Dose One to two tablets (depending on strength) every 4 to 6 hours, as needed.
Daily Maximum Do not exceed eight tablets (equivalent to 4000 mg Paracetamol) in any 24-hour period.
Duration Limit Use is strictly limited to a maximum of three consecutive days.
Food Relation May be taken with or without food.
Missed Dose Do not take a double dose to compensate for a missed dose.

Population-Specific Rules

Use of Codeine is restricted in children younger than 12 years of age. For adolescents aged 12 to 15 years, the maximum dose is reduced to one tablet every 6 hours, not exceeding four tablets in 24 hours. A reduced dose or careful monitoring is required for older adults and patients with known renal or hepatic impairment.

Recent Clinical Evidence

Panadeine Extra: Recent Clinical Evidence

Panadeine Extra is a combination medicine containing paracetamol (acetaminophen) and a lower dose of codeine phosphate. Research focuses primarily on the efficacy and safety profile of this specific drug combination, particularly for short-term management of mild to moderate pain.


Efficacy in Acute Pain

Clinical data consistently support the use of combination analgesics for pain relief that is not adequately managed by paracetamol alone. The addition of codeine allows for a different analgesic pathway.

Area of Research Key Findings in Adults
Post-Operative Pain Several randomized controlled trials (RCTs) demonstrated that the paracetamol/codeine combination provided greater pain relief compared to placebo or paracetamol alone following dental and minor surgical procedures.
Headache/Migraine Some studies have evaluated this combination for acute migraine and tension headaches, finding moderate success when used intermittently. Prolonged use for headache is generally discouraged due to the risk of medication-overuse headache.

Safety and Tolerance Profile

When reviewing the safety of the combination, studies focus on the known side effects of both components. Paracetamol's primary risk relates to hepatotoxicity (liver damage) at doses exceeding recommended limits. Codeine's risks include gastrointestinal effects, central nervous system depression, and dependency potential with extended use.

  • Observed Side Effects: The most common adverse effects reported in trials included dizziness, drowsiness, nausea, and constipation, which are primarily attributed to the codeine component.
  • Short-Term Use: Due to the risk of dependency and adverse effects, the combination is consistently recommended for use over the shortest duration possible, often limited to three days or less in non-hospital settings.

Note: The effectiveness of codeine is influenced by individual genetic variability in metabolizing enzymes (CYP2D6), which affects the conversion of codeine to morphine. This variability contributes to differences in analgesic response among patients.

Key Studies & References

  1. Acetaminophen (Paracetamol) Drug Label and Professional Monograph (General)
  2. Systematic review of the efficacy and safety of co-codamol for post-operative pain

Frequently Asked Questions (FAQ)

Common questions about Panadeine Extra (FAQ)

Q: Are there any common over-the-counter medications that interact with Panadeine Extra?

Official product information advises against taking this product with any other medicine containing either paracetamol or codeine, as this significantly increases the risk of overdose. Official guidance also suggests caution with central nervous system (CNS) depressants, which can include some over-the-counter antihistamines or sleeping aids.

Q: Does the body build up a tolerance to the codeine in Panadeine Extra over time?

Official drug documents state that psychological dependence, physical dependence, and tolerance are potential developments noted for codeine-containing products used repeatedly and for prolonged periods. For this reason, official guidance emphasizes short-term use.

Q: What types of allergic reactions are possible with Panadeine Extra?

The product's label documents serious allergic reactions, which include signs such as swelling of the face, mouth, and throat, difficulty breathing, rash, and itching. Rare but severe skin reactions, such as Stevens-Johnson Syndrome, are also noted in official safety information.

Q: Does Panadeine Extra interact with herbal remedies like St. John's Wort?

Regulatory data indicates that St. John's Wort may affect the way your body processes codeine. This could potentially lead to reduced pain relief and, in rare instances, symptoms related to serotonin excess. Caution is always advised when combining this medicine with any herbal remedy.

Q: Is Panadeine Extra a type of Non-Steroidal Anti-Inflammatory Drug (NSAID)?

No, the medicine is not classified as an NSAID. The paracetamol (acetaminophen) component is officially described as a non-opioid, non-salicylate analgesic (pain reliever) and antipyretic (fever reducer).

Q: How long does it usually take for Panadeine Extra to start working?

Regulatory-sourced data indicates that the onset of action for combination analgesics that contain codeine is typically within 15 to 30 minutes. This timeline refers to when the effects of the active ingredients begin to be felt.

Q: Why is Panadeine Extra sometimes kept behind the pharmacy counter?

In many regions, the codeine component means the medicine is subject to regulatory reclassification or specific restrictions. These restrictions are put in place due to the risks of abuse and dependence associated with codeine, leading to it being held in a restricted area or requiring a pharmacist's intervention for sale.

Q: Is it true that Panadeine Extra contains caffeine?

Some formulations that are marketed under the 'Extra' name contain caffeine (often 65 mg) as an additional active ingredient. This is included alongside the paracetamol and codeine components.

Q: What is the purpose of the caffeine in Panadeine Extra?

When caffeine is present in the formulation, it is generally included as a pain reliever aid. This is a common practice in combination analgesic products designed for enhanced effect.

Q: Can Panadeine Extra be taken by someone who has high blood pressure?

Official warnings primarily advise caution for patients with low blood pressure. This is due to the risk of the codeine component causing the blood vessels to widen, which can lead to low blood pressure. High blood pressure itself is not listed as an absolute contraindication in official documents.

Q: What happens if Panadeine Extra is taken with a cup of coffee?

If the specific formulation contains caffeine, regulatory documents advise limiting the use of other caffeine-containing foods or beverages, such as coffee. This is done to prevent taking in too much caffeine, which can cause side effects like nervousness, irritability, and a rapid heartbeat.

Q: What is the difference between Panadeine Extra and Panadeine Forte?

Regulatory sources indicate that Panadeine Forte is a prescription-only product generally described as being for severe pain. It typically contains a greater quantity of codeine than Panadeine Extra.

Q: Does Panadeine Extra contain ibuprofen?

No. The active ingredients in this combination product are strictly defined as paracetamol (acetaminophen) and codeine. Ibuprofen is not listed as an active ingredient in this formulation.

Q: Does Panadeine Extra require a prescription in some countries?

Yes, the regulatory status of this medicine varies by country. Due to the risks associated with the codeine component, regulatory bodies in some regions have reclassified the product, making it available only with a medical prescription.

Q: Are there official restrictions on buying Panadeine Extra?

Official drug documents reflect that regulatory bodies in various regions have implemented restrictions on the purchase of codeine-containing products. These measures are intended to limit the risk of abuse and dependence, and may include prescription-only status or reducing the pack sizes available for sale.

Q: What does 'Extra' in the drug name refer to?

In this product line, the term 'Extra' typically indicates that the formulation contains additional active ingredients beyond the single-ingredient paracetamol. This usually refers to the inclusion of codeine and often caffeine in many over-the-counter versions.

Q: Can Panadeine Extra be used for period pain?

The medicine is generally indicated for the short-term relief of moderate to strong pain. Clinical trials of similar combination analgesics have included the examination of their use for premenstrual and menstrual cramps.

Q: Why are the packs sometimes small in certain stores?

Regulatory bodies in some regions have introduced official restrictions to reduce the maximum pack size sold at one time. This measure is intended to limit the total amount of codeine a patient can purchase, thereby discouraging misuse and dependence.

Q: Does Panadeine Extra contain aspirin?

The formulation that combines paracetamol and codeine does not typically list aspirin as an active ingredient. The combination is primarily focused on the actions of paracetamol and codeine.

Q: Can Panadeine Extra affect blood tests or medical procedures?

Regulatory documents note a specific interaction with laboratory tests. The codeine component may potentially increase the level of serum amylase detected during certain blood tests.

How should Panadeine Extra be stored and disposed of?

How to Store and Dispose of Panadeine Extra?

The official storage and disposal guidelines for Panadeine Extra (Acetaminophen and Codeine) are defined by regulatory agencies to ensure stability and public safety.

Storage Requirements

Detail Official Requirement
Temperature Store below 25°C in a cool, dry place (room temperature).
Environment Protect from excess heat and moisture (do not store in bathrooms); keep from freezing.
Packaging Must be stored in its original closed container and blister pack.
Child Safety Keep out of the sight and reach of children and store in a secure, locked location.

Disposal Instructions

Because of the Codeine component, the product must be disposed of safely. Do not flush the medicine down the toilet or throw it in the household trash. Unused or expired tablets must be returned to a local community pharmacy or an authorized drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Panadeine Extra found in:

A-Z Index: